by Payash Bahuguna | Jan 18, 2024 | PR
Iktos announces the appointment of Avirup Bose as Chief Business Officer. At Iktos, Avirup will lead the global business development team to drive business strategy. He will also be a member of the executive committee and will work together to develop the company...
by Payash Bahuguna | Jan 10, 2024 | Blog
Iktos has been featured in an insightful article by European Pharmaceutical Manufacturer, shedding light on our groundbreaking collaboration with Nerviano Medical Sciences S.r.l. The article delves into our collaboration agreement, focusing on an unprecedented kinase...
by Payash Bahuguna | Jan 10, 2024 | Blog
We are thrilled to share that Iktos has been prominently featured in an article by MyPharma Editions! This spotlight is on our groundbreaking collaboration with Nerviano Medical Sciences, leveraging the power of AI for the discovery of novel drugs in the fight against...
by Payash Bahuguna | Jan 8, 2024 | PR
Iktos and Nerviano Medical Sciences S.r.l (NMS), a leading Italian clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, announced a collaboration agreement in AI for unprecedented kinase project. As per the agreement, NMS...
by Payash Bahuguna | Dec 18, 2023 | Blog
Maddyness recently explored the heart of innovation at the Iktos headquarters in Paris, France. Their latest article delves into our mission to propel the pharmaceutical industry forward by seamlessly merging AI and robotics. Together, we’re pushing the...